A

Astec Lifesciences Ltd
NSE:ASTEC

Watchlist Manager
Astec Lifesciences Ltd
NSE:ASTEC
Watchlist
Price: 1 085.1 INR 0.09% Market Closed
Market Cap: 21.3B INR
Have any thoughts about
Astec Lifesciences Ltd?
Write Note

Wall Street
Price Targets

ASTEC Price Targets Summary
Astec Lifesciences Ltd

Wall Street analysts forecast ASTEC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASTEC is 1 530 INR with a low forecast of 1 515 INR and a high forecast of 1 575 INR.

Lowest
Price Target
1 515 INR
40% Upside
Average
Price Target
1 530 INR
41% Upside
Highest
Price Target
1 575 INR
45% Upside
Astec Lifesciences Ltd Competitors:
Price Targets
BAYERCROP
Bayer Cropscience Ltd
8% Upside
DEEPAKFERT
Deepak Fertilisers and Petrochemicals Corp Ltd
23% Upside
000902
Xinyangfeng Agricultural Technology Co Ltd
22% Upside
600486
Jiangsu Yangnong Chemical Co Ltd
30% Upside

Revenue
Forecast

Revenue Estimate
Astec Lifesciences Ltd

For the last 8 years the compound annual growth rate for Astec Lifesciences Ltd's revenue is 8%. The projected CAGR for the next 3 years is 29%.

8%
Past Growth
29%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Astec Lifesciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Astec Lifesciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ASTEC's stock price target?
Price Target
1 530 INR

According to Wall Street analysts, the average 1-year price target for ASTEC is 1 530 INR with a low forecast of 1 515 INR and a high forecast of 1 575 INR.

What is Astec Lifesciences Ltd's Revenue forecast?
Projected CAGR
29%

For the last 8 years the compound annual growth rate for Astec Lifesciences Ltd's revenue is 8%. The projected CAGR for the next 3 years is 29%.

Back to Top